Clinical trials
Breast Neoplasms trials in Pakistan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
47 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 2 |
| 2006 | 2 |
| 2007 | 3 |
| 2008 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 5 |
| 2023 | 3 |
| 2024 | 6 |
| 2025 | 4 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 29 |
| Active, not recruiting | 6 |
| Unknown status | 6 |
| Recruiting | 3 |
| Not yet recruiting | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Aga Khan University | 5 |
| GlaxoSmithKline | 4 |
| Novartis Pharmaceuticals | 4 |
| Shaukat Khanum Memorial Cancer Hospital & Research Centre | 4 |
| Hoffmann-La Roche | 3 |
| Riphah International University | 3 |
| Superior University | 3 |
| Liaquat University of Medical & Health Sciences | 2 |
| Pakistan Institute of Living and Learning | 2 |
| Aga Khan University Hospital, Pakistan | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 47 |
| Pain | 2 |
| Agnosia | 1 |
| Breast Cancer Lymphedema | 1 |
| COVID-19 | 1 |
| Cachexia | 1 |
| Chronic Pain | 1 |
| Genetic Predisposition to Disease | 1 |
| Inflammatory Breast Neoplasms | 1 |
| Lymphatic Metastasis | 1 |
Trials
Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.